Perpetua Medical AB (publ), formerly Pharmacolog I Uppsala AB (publ), is a Sweden-based medical technology company that develops systems and solutions which aim to optimize and ensure correct and effective treatment with injectable drugs. The Company provides solutions and products that verifies that drugs and narcotics used in surgery have not been tampered with, its solutions make a vital contribution to preventing drug diversion. Its products Pharmacolog Dashboard offers a variety of valuable tools, generating reports and statistical analyses of validated pharmaceuticals. Another product WasteLog is a device that manages the workflow by instantly analyzing the waste and returns of injectable controlled substances.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

11-19 Earnings release - Q3 2026

More about the company

Market Cap	20.79M 2.07M 1.85M 1.72M 1.57M 2.95M 199M 2.97M 8.09M 102M 7.77M 7.6M 327M	P/E 2024	-7.35x	P/E 2025	10.1x
Enterprise Value	29.28M 2.92M 2.6M 2.42M 2.21M 4.15M 281M 4.18M 11.39M 143M 10.95M 10.71M 461M	EV / Sales 2024	2.01x	EV / Sales 2025	2.23x
Free-Float	53.71%	Yield 2024 *	-	Yield 2025	-

08-21	Perpetua Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-21	Perpetua Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-20	Perpetua Medical Q4 oper loss widens to SEK 3.9 mln	RE
02-20	Perpetua Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
12-19	Perpetua Medical approves directed new issue of up to 2,355,713 shares	RE
11-06	Perpetua Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-06	Perpetua Medical Q3 net sales at SEK 3.48 mln	RE
25-10-20	Perpetua Medical's subsidiary gets significant order	RE
25-08-29	Perpetua Medical to buy 51% of Spirotronic Ab	RE
25-08-22	Perpetua Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-08-22	Perpetua Medical Q2 oper loss SEK 0.5 mln	RE
25-07-20	Pharmacolog Usa Inc acquired Remaining Assets from Perpetua Medical AB (OM:PERP B).	CI
25-07-08	Perpetua Medical agrees to sell assets for sek 10 mln	RE

11-06	Perpetua Medical Q3 net sales at SEK 3.48 mln	RE
25-01-02	Eyeon and Oodash 2024 winners on First North, NGM, Nordic SME and Spotlight	FW
23-12-30	Hilbert this year's winner and Quiapeg this year's loser on First North 2023	FW

24-05-17	Perpetua Medical publishes interim report January - March 2024	AQ
24-04-24	Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO	AQ
24-04-23	Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name	AQ
24-04-16	ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024	AQ
24-04-16	Pharmacolog publishes annual report for 2023	AQ

Manager	Title	Age	Since
Anders Hedlund CEO	Chief Executive Officer	-	2024-04-30
Hans Erik Dahlin CEO	Chief Executive Officer	81	2007-01-14
Camilla Lönn DFI	Director of Finance/CFO	54	2024-04-23

Pharmacolog i Uppsala AB (publ) Stock OTC Markets

Stocks

PUPPF

SE0011178763

Advanced Medical Equipment & Technology

Valuation: Pharmacolog i Uppsala AB (publ)

Latest news: Pharmacolog i Uppsala AB (publ)

Analysts' recommendations: Pharmacolog i Uppsala AB (publ)

Press Releases: Pharmacolog i Uppsala AB (publ)

Managers and Directors: Pharmacolog i Uppsala AB (publ)

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Director	Title	Age	Since
Jonas Erik Anders Hedlund CHM	Chairman	78	2016-12-31
Ragnar Linder BRD	Director/Board Member	73	2018-12-31
Anders Hedlund BRD	Director/Board Member	-	2023-06-29

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PHARMACOLOG I UPPSALA AB (PUBL)	-.--%	+62.34%	-	-	2.07M
THERMO FISHER SCIENTIFIC, INC.	-2.31%	-2.93%	+21.29%	+32.33%	250B
DANAHER CORPORATION	-1.73%	-4.13%	+2.39%	-0.21%	156B
INTUITIVE SURGICAL, INC.	-0.46%	-1.67%	-9.87%	+37.07%	144B
BOSTON SCIENTIFIC CORPORATION	-0.05%	-2.80%	-55.89%	-18.17%	61.45B
EDWARDS LIFESCIENCES CORPORATION	-0.05%	-1.09%	+13.79%	+18.21%	50.28B
SIEMENS HEALTHINEERS AG	+1.70%	-1.50%	-21.21%	-19.75%	46.73B
AGILENT TECHNOLOGIES, INC.	-0.65%	-3.17%	+19.68%	+53.18%	48.29B
VEEVA SYSTEMS INC.	+0.80%	+2.44%	-4.80%	+36.15%	45.89B
WATERS CORPORATION	-0.47%	-1.47%	+33.31%	+63.33%	43.24B
Average	-0.35%	-2.32%	-0.15%	+22.46%	93.91B
Weighted average by Cap.	-1.07%	-2.77%	+3.22%	+22.74%

	2024	2025
Net sales	6.94M 691K 616K 574K 523K 984K 66.54M 991K 2.7M 33.96M 2.59M 2.54M 109M	14.56M 1.45M 1.29M 1.21M 1.1M 2.07M 140M 2.08M 5.66M 71.27M 5.44M 5.33M 229M
Net income	-2.47M -246K -220K -205K -186K -351K -23.72M -353K -962K -12.1M -924K -905K -38.91M	2.45M 244K 218K 203K 185K 348K 23.51M 350K 954K 12M 916K 897K 38.57M
Net Debt	-5.4M -538K -480K -447K -407K -766K -51.79M -772K -2.1M -26.43M -2.02M -1.98M -84.96M	8.49M 845K 754K 702K 639K 1.2M 81.4M 1.21M 3.3M 41.55M 3.17M 3.1M 134M